IMRIS Inc. announced the sale of IMRISneuro to CEA-LETI for CLINATEC(R) in Grenoble, France. Within CEA-LETI, CLINATEC(R) is a biomedical research initiative in partnership with Grenoble University Hospital (CHU) dedicated to advancing micro nanotechnologies in support of developing therapeutic solutions for... (Continue reading)